Ipsophene: The Future of French Paracetamol

Europe's first paracetamol production plant with a production line entirely located in France!

Who are we?

Ipsophène is an innovative company founded in 2021, dedicated to the local production of the active ingredient in paracetamol-based medicines in France.

Located in Toulouse, we use a continuous manufacturing process pioneered in the pharmaceutical industry and developed by our team of expert researchers.

Our mission is to strengthen France’s healthcare independence by locally producing essential components for medicines, while minimizing our environmental impact.

Backed by strategic partners and regional funds, we aim to meet a third of French demand for paracetamol by 2026.

The product

At Ipsophène, our paracetamol stands out for its excellent quality and innovative manufacturing process, which guarantees total manufacturing autonomy, even in the event of an international crisis.

Thanks to our continuous production technology, we significantly reduce manufacturing time and waste, while keeping costs competitive.

Made from French and European raw materials, our paracetamol guarantees optimum purity and consistent efficacy.

We are committed to providing a reliable product for pharmaceutical laboratories and consumers, while contributing to the reindustrialization of France.

By choosing paracetamol from Ipsophene, you support sustainable, high-quality local production, ensuring the availability of an essential medicine.

100%

Made in France

100%

Continuous flow manufacturing

30x

Less waste

CSR

At Ipsophène, our commitment to CSR is at the heart of our business.

We firmly believe in environmentally-friendly production, reducing our ecological footprint through innovative processes that minimize waste and the use of resources.

We also value the well-being of our employees, providing a safe, inclusive and stimulating working environment.
Our aim is to contribute positively to society by supporting the local economy, creating jobs and ensuring quality, ethical and sustainable pharmaceutical production.

By choosing Ipsophène, you are supporting the values of transparency, responsible innovation and sustainable development.

Continuous flow paracetamol production

The press

Discover the latest news and reports on our revolutionary project to produce 100% French paracetamol.

Press article

Date : 23 octobre 2024

100% français, moins polluant...Ipsophene, ce producteur toulousain de paracétamol passé inaperçu

Reading time: 15 min

Alors que la cession du groupe Opella par Sanofi au fond américain CD & R ulcère toute une partie de la classe politique, une entreprise française s’approche à grands pas de l'objectif de souveraineté sanitaire fixé par le gouvernement : bâtir une filière 100 % française. Sans jouir pourtant de l'attention de l’État, davantage intéressé par les géants pharmaceutiques que par la société toulousaine.

Read the article

Press article

Date : 22 octobre 2024

Paracétamol : le casse-tête d'une production souveraine

Reading time: 16 min

Au-delà de la polémique de la vente du Doliprane à un fonds américain, le véritable enjeu de souveraineté se situe davantage sur l'approvisionnement de son principe actif, le paracétamol. En la matière, des acteurs préparent la sortie de terre de deux usines pour un paracétamol tricolore.

Read the article